9989 — Sundrug Co Income Statement
0.000.00%
Last trade - 00:00
- ¥512bn
- ¥444bn
- ¥690bn
- 97
- 46
- 86
- 93
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
Standards: | JAS | JAS | JAS | JAS | JAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 588,069 | 617,769 | 634,310 | 648,734 | 690,462 |
Cost of Revenue | |||||
Gross Profit | 147,178 | 154,619 | 158,550 | 156,506 | 171,946 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 553,565 | 583,676 | 598,124 | 614,974 | 653,578 |
Operating Profit | 34,504 | 34,093 | 36,186 | 33,760 | 36,884 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35,071 | 34,648 | 37,188 | 34,675 | 37,710 |
Provision for Income Taxes | |||||
Net Income After Taxes | 23,934 | 23,692 | 25,329 | 23,854 | 25,703 |
Net Income Before Extraordinary Items | |||||
Net Income | 23,934 | 23,692 | 25,329 | 23,854 | 25,703 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 23,933 | 23,692 | 25,329 | 23,853 | 25,703 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 209 | 217 | 223 | 204 | 222 |
Dividends per Share |